Does PERTUZUMAB Cause Metastases to lung? 195 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Metastases to lung have been filed in association with PERTUZUMAB (PERJETA). This represents 0.9% of all adverse event reports for PERTUZUMAB.
195
Reports of Metastases to lung with PERTUZUMAB
0.9%
of all PERTUZUMAB reports
22
Deaths
23
Hospitalizations
How Dangerous Is Metastases to lung From PERTUZUMAB?
Of the 195 reports, 22 (11.3%) resulted in death, 23 (11.8%) required hospitalization, and 7 (3.6%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 195 reports have been filed with the FAERS database.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
Which PERTUZUMAB Alternatives Have Lower Metastases to lung Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN